Med Life Dividends and Buybacks
Dividend criteria checks 0/6
Med Life does not have a record of paying a dividend.
Key information
n/a
Dividend yield
0.04%
Buyback Yield
| Total Shareholder Yield | 0.04% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Is Med Life S.A. (BVB:M) Trading At A 41% Discount?
Aug 06
The Market Lifts Med Life S.A. (BVB:M) Shares 25% But It Can Do More
Jun 08Is Med Life (BVB:M) A Risky Investment?
Apr 05Returns On Capital Signal Tricky Times Ahead For Med Life (BVB:M)
Jul 05Is Med Life (BVB:M) A Risky Investment?
Jan 06Med Life (BVB:M) Hasn't Managed To Accelerate Its Returns
Dec 06We Think Med Life (BVB:M) Is Taking Some Risk With Its Debt
Sep 27Returns Are Gaining Momentum At Med Life (BVB:M)
May 05Is There An Opportunity With Med Life S.A.'s (BVB:M) 49% Undervaluation?
Mar 01Med Life (BVB:M) Shareholders Will Want The ROCE Trajectory To Continue
Jan 22Does Med Life (BVB:M) Have A Healthy Balance Sheet?
Aug 31Med Life's (BVB:M) Returns On Capital Are Heading Higher
Jun 10Here's Why We Think Med Life (BVB:M) Is Well Worth Watching
May 26Is Now An Opportune Moment To Examine Med Life S.A. (BVB:M)?
May 12Is There An Opportunity With Med Life S.A.'s (BVB:M) 24% Undervaluation?
Apr 12Update: Med Life (BVB:M) Stock Gained 98% In The Last Year
Mar 16Should We Be Excited About The Trends Of Returns At Med Life (BVB:M)?
Mar 04Should You Be Impressed By Med Life S.A.'s (BVB:M) ROE?
Feb 20
Med Life (BVB:M) Seems To Use Debt Quite Sensibly
Feb 07Is It Too Late To Consider Buying Med Life S.A. (BVB:M)?
Jan 25Do Med Life's (BVB:M) Earnings Warrant Your Attention?
Jan 08Is Med Life S.A. (BVB:M) Trading At A 22% Discount?
Dec 23Did You Miss Med Life's (BVB:M) 49% Share Price Gain?
Dec 08The Trends At Med Life (BVB:M) That You Should Know About
Nov 24Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if M's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if M's dividend payments have been increasing.
Dividend Yield vs Market
| Med Life Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (M) | n/a |
| Market Bottom 25% (RO) | 2.8% |
| Market Top 25% (RO) | 7.4% |
| Industry Average (Healthcare) | 2.1% |
| Analyst forecast (M) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate M's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate M's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate M's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as M has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/17 09:04 |
| End of Day Share Price | 2025/01/17 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Med Life S.A. is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Caius Rapanu | Erste Group Bank AG |
| Catalin Diaconu | Raiffeisen Bank International AG - Institutional Equity |
| Maria Magherusan | SSIF BRK Financial Group S.A. |